Global Journal of Transfusion Medicine

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 7  |  Issue : 1  |  Page : 18--22

Influence of Pretransplant Anemia on Red Blood Cell Transfusions in Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation


Merline Augustine1, Mohandoss Murugesan2, Chandran K Nair3, Sangeetha Keloth Nayanar4 
1 Department of Transfusion Medicine, Goa Medical College, Bambolim, Goa, India
2 Department of Transfusion Medicine, Malabar Cancer Centre, Thalassery, Kerala, India
3 Department of Clinical Hematology and Medical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India
4 Department of Oncopathology, Malabar Cancer Centre, Thalassery, Kerala, India

Correspondence Address:
Dr. Mohandoss Murugesan
Department of Transfusion Medicine, Malabar Cancer Centre, Thalassery, Kerala
India

Background and Objectives: Anemia during peripheral blood stem cells (PBSCs) transplant is considered a bad prognostic marker. The study aimed to determine whether pretransplant anemia influence peritransplant transfusion requirements in myeloma patients. Methods: Myeloma patients planned for PBSC transplant were stratified based on hemoglobin levels at time of mobilization, PBSC collection, and PBSC infusion. Univariate and multivariate analysis was performed to study the predictors for good mobilization, adequate CD34 yield by apheresis, and red blood cell (RBC) transfusion in the peritransplant period. Results: Of 67 patients, the prevalence of anemia at mobilization, PBSC collection, and PBSC infusion was 37%, 58%, and 70%, respectively. Eighty-five percent had good mobilization with peripheral blood CD34 count of 50 cells/μl (8–123) and 81% had adequate CD34 yield with first apheresis. Thirty-two percent patients received peritransplant RBC transfusion with the median of one unit (range: 0–5). Anemia on the day of infusion did influence the RBC transfusions in the peritransplant period (P = 0.03). Conclusion: One third of myeloma patients require RBC transfusion support in the peritransplant period. We identified pretransplant anemia neither influenced mobilization nor PBSC collection but increased the risk for RBC transfusion in the peritransplant period.


How to cite this article:
Augustine M, Murugesan M, Nair CK, Nayanar SK. Influence of Pretransplant Anemia on Red Blood Cell Transfusions in Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.Glob J Transfus Med 2022;7:18-22


How to cite this URL:
Augustine M, Murugesan M, Nair CK, Nayanar SK. Influence of Pretransplant Anemia on Red Blood Cell Transfusions in Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation. Glob J Transfus Med [serial online] 2022 [cited 2022 May 26 ];7:18-22
Available from: https://www.gjtmonline.com/article.asp?issn=2468-8398;year=2022;volume=7;issue=1;spage=18;epage=22;aulast=Augustine;type=0